Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism.
Allergy 2008 Jun;63(6):728-34
abstract
_______________________________________________________________
13
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Allergy 2008 Jun;63(6):742-50
abstract
_______________________________________________________________
14
Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema.
Allergy 2008 Jun;63(6):751-7
abstract
_______________________________________________________________
15
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites.
Allergy 2008 Jun;63(6):758-67
abstract
_______________________________________________________________
16
Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana.
Allergy 2008 Jun;63(6):768-76
abstract
_______________________________________________________________
17
How to assess disease activity in patients with chronic urticaria?
Allergy 2008 Jun;63(6):777-80
abstract
_______________________________________________________________
18
Do we have to recommend not using oat-containing emollients in children with atopic dermatitis?
Allergy 2008 Jun;63(6):781-2
abstract
_______________________________________________________________
19
Response to Campbell, Spackman, Sullivan letter to Allergy.
Allergy 2008 Jun;63(6):783
abstract
_______________________________________________________________
20
Anaphylactic shock after intradermal testing with betalactam antibiotics.
Allergy 2008 Jun;63(6):785
abstract
_______________________________________________________________
21
DRESS syndrome induced by sodium meglumine ioxitalamate.
Allergy 2008 Jun;63(6):786-7
abstract
_______________________________________________________________
22
Delayed hypersensitivity to acylureidopenicillins: a case report.
Allergy 2008 Jun;63(6):787-9
abstract
_______________________________________________________________
23
Localized cold-induced urticaria associated with specific immunotherapy for tree pollen allergy.
Allergy 2008 Jun;63(6):789-90
abstract
_______________________________________________________________
24
Omalizumab in persistent severe bakers' asthma.
Allergy 2008 Jun;63(6):790-1
abstract
_______________________________________________________________
25
Improving latex-allergy diagnosis: the clinical role of Hev b8-specific IgE.
Allergy 2008 May;63(5):620-621
_______________________________________________________________
26
Occupational allergy in a researcher due to Ole e 9, an allergenic 1,3-beta-glucanase from olive pollen.
Allergy 2008 Jun;63(6):784-5
abstract
_______________________________________________________________
27
Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Allergy 2008 Jun;63(6):712-9
abstract
_______________________________________________________________
28
In Allergy, 'A new day has begun'.
Allergy 2008 Jun;63(6):631-3
abstract
_______________________________________________________________
29
Finnish Allergy Programme 2008-2018--time to act and change the course.
Allergy 2008 Jun;63(6):634-45
abstract
_______________________________________________________________
30
House dust mite control measures for asthma: systematic review.
Allergy 2008 Jun;63(6):646-59
abstract
_______________________________________________________________
31
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.
Allergy 2008 Jun;63(6):660-9
abstract
_______________________________________________________________
32
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
Allergy 2008 Jun;63(6):670-84
abstract
_______________________________________________________________
33
Mechanisms of asthma in Olympic athletes--practical implications.
Allergy 2008 Jun;63(6):685-94
abstract
_______________________________________________________________
34
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
Allergy 2008 Jun;63(6):720-7
abstract
_______________________________________________________________
35
Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report*
Allergy 2008 July;63(7):793-796
abstract
_______________________________________________________________
36
Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.
Allergy 2008 Jun 10; [ahead of print]
abstract
_______________________________________________________________
37
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).
Allergy 2008 Apr;63 Suppl 86
abstract
_______________________________________________________________
38
Rupatadine in allergic rhinitis and chronic urticaria.
Allergy 2008 Apr;63 Suppl 87
abstract
_______________________________________________________________
39
Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine: a case-control study.
Allergy 2008 Mar 29; [ahead of print]
abstract
_______________________________________________________________
40
Prevalence of asthma in a large group of Israeli adolescents: influence of country of birth and age at migration.
Allergy 2008 Mar 29; [ahead of print]
abstract
_______________________________________________________________
41
Sputum neurokinin A in Egyptian asthmatic children and adolescents: relation to exacerbation severity.
Allergy 2008 May 27; [ahead of print]
abstract
_______________________________________________________________
42
A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy.
Allergy 2008 May 27; [ahead of print]
abstract
_______________________________________________________________
43
Wheat allergen exposure and the prevalence of work-related sensitization and allergy in bakery workers.
Allergy 2008 May 30; [ahead of print]
abstract
_______________________________________________________________
44
Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases.
Allergy 2008 Jun 10; [ahead of print]
abstract
_______________________________________________________________
45
The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility.
Allergy 2008 Jun 10; [ahead of print]
abstract
_______________________________________________________________
46
A population-based epidemiologic analysis of deaths from anaphylaxis in Florida.
Allergy 2008 Jun 10; [ahead of print]
abstract
_______________________________________________________________
47
Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha -308 promoter polymorphism in northeastern Mexico.
Allergy Asthma Proc 2008 Jun 4; [ahead of print]
abstract
_______________________________________________________________
48
Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids.
Allergy Asthma Proc 2008 May-Jun;29(3):232-40
abstract
_______________________________________________________________
49
Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity.
Allergy Asthma Proc 2008 May-Jun;29(3):241-9
abstract
_______________________________________________________________
50
Analysis of high-affinity IgE receptor (FcepsilonR1) polymorphisms in patients with aspirin-intolerant chronic urticaria.
Allergy Asthma Proc 2008 May-Jun;29(3):250-7
abstract
_______________________________________________________________
51
1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase.
Allergy Asthma Proc 2008 May-Jun;29(3):258-67
abstract
_______________________________________________________________
52
Gene polymorphisms of tumor necrosis factor alpha-308 and interleukin-10-1082 among asthmatic Egyptian children.
Allergy Asthma Proc 2008 May-Jun;29(3):268-73
abstract
_______________________________________________________________
53
Effect of specific immunotherapy on serum levels of tumor necrosis factor alpha in asthmatic children.
Allergy Asthma Proc 2008 May-Jun;29(3):274-9
abstract
_______________________________________________________________
54
Asthma control in pediatric patients treated with once-daily or twice-daily nebulized budesonide inhalation suspension (Pulmicort Respules).
Allergy Asthma Proc 2008 May-Jun;29(3):280-5
abstract
_______________________________________________________________
55
Minocycline treatment results in reduced oral steroid requirements in adult asthma.
Allergy Asthma Proc 2008 May-Jun;29(3):286-94
abstract
_______________________________________________________________
56
Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact.
Allergy Asthma Proc 2008 May-Jun;29(3):295-303
abstract
_______________________________________________________________
57
Enhancement of basophil apoptosis by olopatadine and theophylline.
Allergy Asthma Proc 2008 May-Jun;29(3):322-8
abstract
_______________________________________________________________
58
Monitoring of peanut-allergic patients with peanut-specific IgE.
Allergy Asthma Proc 2008 May-Jun;29(3):329-35
abstract
_______________________________________________________________
59
Systematic evaluation and treatment of chronic cough in a community setting.
Allergy Asthma Proc 2008 May-Jun;29(3):336-42
abstract
_______________________________________________________________
60
Nontuberculous mycobacterial infection in the differential diagnosis of chronic cough.
Allergy Asthma Proc 2008 May-Jun;29(3):343-4
abstract
_______________________________________________________________
61
Liver enzyme elevation and normal pulmonary function in an adult with a declining forced expiratory volume in 1 second.
Allergy Asthma Proc 2008 May-Jun;29(3):345-8
abstract
_______________________________________________________________
62
In Memoriam: Donald C. Fournier, M.D. (1949 - 2008).
Allergy Asthma Proc 2008 Mar-Apr;29(2):16
abstract
_______________________________________________________________
63
Is asthma in childhood different from asthma in adults? Why do we need special approaches to asthma in children?
Allergy Asthma Proc 2008 Mar-Apr;29(2):99-102
abstract
_______________________________________________________________
64
The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
Allergy Asthma Proc 2008 Mar-Apr;29(2):103-8
abstract
_______________________________________________________________
65
Pharmacoeconomic review of medical management of persistent asthma.
Allergy Asthma Proc 2008 Mar-Apr;29(2):109-22
abstract
_______________________________________________________________
66
Harmonia axyridis ladybug invasion and allergy.
Allergy Asthma Proc 2008 Mar-Apr;29(2):123-9
abstract
_______________________________________________________________
67
Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy.
Allergy Asthma Proc 2008 Mar-Apr;29(2):130-9
abstract
_______________________________________________________________
68
The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence.
Allergy Asthma Proc 2008 Mar-Apr;29(2):140-5
abstract
_______________________________________________________________
69
Mediator measurements after daily instillation of allergen: Increased IL-5 and decreased IFN-gamma.
Allergy Asthma Proc 2008 Mar-Apr;29(2):146-51
abstract
_______________________________________________________________
70
Risk factors associated with transient wheezing in young children.
Allergy Asthma Proc 2008 Mar-Apr;29(2):161-5
abstract
_______________________________________________________________
71
Prevalence of atopy in children with type 1 diabetes mellitus, hepatitis B virus carriers, and healthy children: role of T helper 1 (Th1)-type immune response.
Allergy Asthma Proc 2008 Mar-Apr;29(2):166-70
abstract
_______________________________________________________________
72
Exhaled nitric oxide levels during treatment in patients hospitalized with asthma.
Allergy Asthma Proc 2008 Mar-Apr;29(2):171-6
abstract
_______________________________________________________________
73
Health care utilization and costs of adult asthma in Taiwan.
Allergy Asthma Proc 2008 Mar-Apr;29(2):177-81
abstract
_______________________________________________________________
74
The effect of enantiomers of beta-agonists on myofibroblast-derived vascular endothelial growth factor and other matrix components in the presence of dust-mite extract.
Allergy Asthma Proc 2008 Mar-Apr;29(2):182-8
abstract
_______________________________________________________________
75
Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
Allergy Asthma Proc 2008 Mar-Apr;29(2):189-96
abstract
_______________________________________________________________
76
Respiratory syncytial virus infection in a Sicilian pediatric population: risk factors, epidemiology, and severity.
Allergy Asthma Proc 2008 Mar-Apr;29(2):205-10
abstract
_______________________________________________________________
77
Epinephrine auto-injector prescriptions as a reflection of the pattern of anaphylaxis in an Asian population.
Allergy Asthma Proc 2008 Mar-Apr;29(2):211-5
abstract
_______________________________________________________________
78
A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis.
Allergy Asthma Proc 2008 Mar-Apr;29(2):216-20
abstract
_______________________________________________________________
79
On the cover. Australian pine.
Ann Allergy Asthma Immunol 2008 May;100(5):A4
abstract
_______________________________________________________________
80
Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1.
Ann Allergy Asthma Immunol 2008 May;100(5):403-11; quiz 412-4, 468
abstract
_______________________________________________________________
81
Evaluation of exhaled nitric oxide measurements in the emergency department for patients with acute asthma.
Ann Allergy Asthma Immunol 2008 May;100(5):415-9
abstract
_______________________________________________________________
82
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
Ann Allergy Asthma Immunol 2008 May;100(5):420-5
abstract
_______________________________________________________________
83
Psychological triggers and hyperventilation symptoms in asthma.
Ann Allergy Asthma Immunol 2008 May;100(5):426-32
abstract
_______________________________________________________________
84
The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.
Ann Allergy Asthma Immunol 2008 May;100(5):433-8
abstract
_______________________________________________________________
85
Asthma and suicidal ideation with and without suicide attempts among adults in the United States: what is the role of cigarette smoking and mental disorders?
Ann Allergy Asthma Immunol 2008 May;100(5):439-46
abstract
_______________________________________________________________
86
A case-control study of body mass index and asthma in Asian children.
Ann Allergy Asthma Immunol 2008 May;100(5):447-51
abstract
_______________________________________________________________
87
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Ann Allergy Asthma Immunol 2008 May;100(5):452-6
abstract
_______________________________________________________________
88
Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.
Ann Allergy Asthma Immunol 2008 May;100(5):457-62
abstract
_______________________________________________________________
89
Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy.
Ann Allergy Asthma Immunol 2008 May;100(5):463-8
abstract
_______________________________________________________________
90
Safety of open food challenges in the office setting.
Ann Allergy Asthma Immunol 2008 May;100(5):469-74
abstract
_______________________________________________________________
91
Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
Ann Allergy Asthma Immunol 2008 May;100(5):475-81
abstract
abstract
_______________________________________________________________
92
Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Ann Allergy Asthma Immunol 2008 May;100(5):482-9
abstract
_______________________________________________________________
93
Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Ann Allergy Asthma Immunol 2008 May;100(5):490-6
abstract
_______________________________________________________________
94
Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
Ann Allergy Asthma Immunol 2008 May;100(5):497-505
abstract
_______________________________________________________________
95
Intranasal corticosteroids and the eye: from negative ocular effects to clinical efficacy as a class effect.
Ann Allergy Asthma Immunol 2008 May;100(5):506-8
abstract
_______________________________________________________________
96
Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment.
Ann Allergy Asthma Immunol 2008 May;100(5):509-11
abstract
_______________________________________________________________
97
Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population.
Ann Allergy Asthma Immunol 2008 May;100(5):512-3
abstract
_______________________________________________________________
98
Immediate-type hypersensitivity reaction to levothyroxine and desensitization.
Ann Allergy Asthma Immunol 2008 May;100(5):513-4
abstract
_______________________________________________________________
99
My research life on allergy. (Japanese)
Arerugi 2008 May;57(5):562-5
abstract
_______________________________________________________________
100
Immunotherapy of hymenoptera allergy. [Japanese]
Arerugi 2008 May;57(5):491-8
abstract
_______________________________________________________________
101
Ebm and future directions of allergen-specific immunotherapy in atopic dermatitis. [Japanese]
Arerugi 2008 May;57(5):499-506
abstract
_______________________________________________________________
102
One point message of JGL2006 (children)--level of severity and control-. [Japanese]
Arerugi 2008 May;57(5):508-12
abstract
_______________________________________________________________
103
Actual methods of skin tests. [Japanese]
Arerugi 2008 May;57(5):513-8
abstract
_______________________________________________________________
104
Immunotherapy for allergic rhinitis induced by Japanese cedar pollens. [Japanese]
Arerugi 2008 May;57(5):519-23
abstract
_______________________________________________________________
105
Skin manifestations of collagen diseases unfamiliar to internists and pediatricians. [Japanese]
Arerugi 2008 May;57(5):524-8
abstract
_______________________________________________________________
106
Gastroesophageal reflux disease in preschool children with asthma. [Japanese]
Arerugi 2008 May;57(5):529-35
abstract
_______________________________________________________________
107
A clinical review of patients with seizures that developed during theophylline administration--(III) Safety of theophylline examined in patients who had sequelae or died. [Japanese]
Arerugi 2008 May;57(5):536-42
abstract
_______________________________________________________________
108
Evaluation of atopy by antigen specific ige antibody. [Japanese]
Arerugi 2008 May;57(5):543-51
abstract
_______________________________________________________________
109
Biotin deficiency by amino acid formula nutrition for an infant with milk protein allergy. [Japanese]
Arerugi 2008 May;57(5):552-7
abstract
_______________________________________________________________
110
The less effect of the immunotherapy for cypress pollinosis by using Japanese cedar pollen extract. [Japanese]
Arerugi 2008 May;57(5):558-61
abstract
_______________________________________________________________
111
Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.
Clin Exp Allergy 2008 Jun;38(6):913-20
abstract
_______________________________________________________________
112
Allergenicity and cross-reactivity of Senecio pollen: identification of novel allergens using the immunoproteomics approach.
Clin Exp Allergy 2008 Jun;38(6):1048-60
abstract
_______________________________________________________________
113
Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen.
Clin Exp Allergy 2008 Jun;38(6):1033-7
abstract
_______________________________________________________________
114
The need for a biological diagnosis of penicillin allergy.
Clin Exp Allergy 2008 Jun;38(6):869-71
abstract
_______________________________________________________________
115
Pathogenesis of asthma.
Clin Exp Allergy 2008 Jun;38(6):872-97
abstract
_______________________________________________________________
116
Latex allergy: a model for therapy.
Clin Exp Allergy 2008 Jun;38(6):898-912
abstract
_______________________________________________________________
117
Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome.
Clin Exp Allergy 2008 Jun;38(6):929-35
abstract
_______________________________________________________________
118
Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Clin Exp Allergy 2008 Jun;38(6):947-56
abstract
_______________________________________________________________
119
Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
Clin Exp Allergy 2008 Jun;38(6):1003-15
abstract
_______________________________________________________________
120
Bakery flour dust exposure causes non-allergic inflammation and enhances allergic airway inflammation in mice.
Clin Exp Allergy 2008 Jun 18; [ahead of print]
abstract
_______________________________________________________________
121
Heterogeneity of commercial timothy grass pollen extracts.
Clin Exp Allergy 2008 Jun 18; [ahead of print]
abstract
_______________________________________________________________
122
Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals.
Clin Exp Allergy 2008 Jun 18; [ahead of print]
abstract
_______________________________________________________________
123
Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates.
Clin Exp Allergy 2008 Jun;38(6):957-67
abstract
_______________________________________________________________
124
Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.
Clin Exp Allergy 2008 Jun;38(6):1016-24
abstract
_______________________________________________________________
125
Asp-Tyr-Leu-Lys tetrapeptide inhibits airway inflammation in toluene-2,4-diisocyanate-induced asthma mice.
